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Abstract. Exposure to profound adversity can negatively affect the neurodevelopment of children, but biologic
mechanisms that underlie this association remain unknown. We sought to determine whether elevated levels of the
inﬂammatory markers C-reactive protein (CRP) and soluble CD14 (sCD14) are associated with neurodevelopmental
outcomes in Bangladeshi children. A total of 422 infant–mother pairs from an urban slum in Dhaka, Bangladesh were
enrolled at birth and followed prospectively. Inﬂammation was measured with sCD14, interleukin (IL)-1β, and IL-6 at
18weeks, andCRP at 6, 18, 40, and 53weeks. Psychologists assessed cognitive, language,motor, and social emotional
development using the Bayley Scales of Infant and Toddler Development at 78 and 104 weeks of age. We tested for the
association of inﬂammatory markers with developmental outcomes, independent of previously identiﬁed associations
such as malnutrition, family income, and maternal education. Every 10 pg/mL increase in sCD14 was associated with a
1.1–2.0 decrement in cognitive andmotor scores at 78weeks and in all domains at 104weeks. The cumulative number of
CRP elevations that a child experienced in the ﬁrst year of life, as well as IL-1β and IL-6 at 18 weeks of age, were also
negativelyassociatedwithBayleyScales results.CRP,sCD14, IL-1β, and IL-6wereassociatedwith lowerneurodevelopmental
outcomes. Our ﬁndings implicate a role of inﬂammation in the neurodevelopment of children growing up in adversity.
INTRODUCTION
Hundreds of millions of children growing up in poverty in
low- and middle-income countries do not meet their full de-
velopmental potentials, which in turn affects their academic
performance and future earnings.1–3 The identiﬁcation of
biomarkers that are associatedwithpoor neurodevelopmental
outcomes offers a promising approach to shed light on bi-
ological mechanisms that underpin the association between
early adversity and development. In recent years, there has
been a particular interest in the association of inﬂammatory
markers with neurodevelopmental outcomes.4–6 The basis
behind studying inﬂammatory markers is rooted in the idea
that inﬂammation is known to be detrimental to the developing
brain as shown in both animal and human studies.7–9
Our group has recently identiﬁed for the ﬁrst time a con-
nection of elevated inﬂammatory markers in children in low-
income countries with neurodevelopmental outcomes. We
found that children from an urban slum in Bangladesh with
higher levels of pro-inﬂammatory cytokines had lower neu-
rodevelopmental scores.6 It, however, remains unknownwhat
is driving cytokine production in these children. Enteric in-
fections remain a leading cause of morbidity in young children
worldwide who carry a disproportionately large share of the
disease burden.10 In this particular cohort of children, enteric
infections are pervasivewith children havingan averageof two
different enteropathogens in their stool by 6 weeks of age.11
As such, inﬂammation triggeredby recurrent enteric infections
early in life may be the driving force behind elevations in sys-
temic inﬂammatory markers in these children.
One important complication of enteric infections, eitherwith
or without overt diarrhea, is environmental enteropathy (EE), a
condition characterized by gut inﬂammation, barrier disrup-
tion, and systemic inﬂammation.12–14 EE is thought to be
caused by repeated enteric infections that results in blunting
of the villi andmicrobial translocation.12 EE has been linked to
poor health outcomes in children including oral vaccine failure
and growth faltering.13,15 Although downstream effects of
EE, such as systemic inﬂammation, have been linked to poor
child development, the association between EE and neuro-
development remains unknown.
Soluble CD14 (sCD14) is an early marker of immune acti-
vation during primary infection of the gut and may serve as a
measure of gut barrier dysfunction.13,16,17 Thus, sCD14 can
serve as a useful surrogate marker for EE.13 CD14 is found
primarily on human monocytes and macrophages and exists
in both membrane-bound and soluble forms. Bacterial prod-
ucts translocated from the gut into the systemic circulation
such as lipopolysaccharide (LPS) can activate CD14 and
result in the release of proinﬂammatory cytokines.18,19 Once
stimulated by LPS, CD14 can shed from monocytes and
macrophages. It can then activate cells that usually lack
CD14 and render them sensitive to activation by LPS. There-
fore, via this pathway, even low levels of LPS can initiate a
cytokine cascade.20 The resultant cytokine cascade includes
the proinﬂammatory cytokines tumor necrosis factor (TNF)-α,
IL-1β, and IL-6, which have been shown to be associated
with poor neurodevelopment.6 However, the association be-
tween sCD14 and neurodevelopmental outcomes remains
unknown.
The goal of this study is twofold: 1) to validate our previous
ﬁndings of inﬂammatory markers in an independent cohort
and 2) to test the hypothesis of a link between EE and
neurodevelopment. To these ends, we aimed to determine
whether elevated levels of sCD14 would be associated with
lower neurodevelopmental scores. We also measured down-
stream inﬂammatory mediators from CD14 activation in-
cluding the proinﬂammatory cytokines TNF-α, IL-1β, IL-6, and
C-reactive protein (CRP). We hypothesized that elevated
* Address correspondence toWilliamA. Petri Jr., Division of Infectious
Diseases and International Health, University of Virginia Health
System, P.O. Box 801340, Charlottesville, VA 22908. E-mail:
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levels of proinﬂammatory cytokines, sCD14, and CRP would
be associated with lower neurodevelopmental scores.
METHODS
Study population and enrollment. We conducted a lon-
gitudinal analysis of 422 infants from a cohort of 700 children
from the PROVIDE study, an ongoing community-based
prospective cohort study of enteric infections and oral
polio vaccine outcomes in infants from a slum of Mirpur in
Dhaka, Bangladesh. The study design and recruitment of the
PROVIDEcohort hasbeenextensivelydescribedpreviously.21
In brief, 700 infants and their mothers were followed from birth
by twiceweekly household visits andscheduledclinic visits for
the ﬁrst 3 years of life. There was rolling admission of subjects
over the ﬁrst 18 months and the study period reported here
spanned from May 2011 to November 2014. The study was
approved by the Ethical Review Board of the International
Centre for Diarrhoeal Disease Research, Bangladesh, as
well as by the Institutional Review Boards of the University of
Virginia and the University of Vermont.
Anthropometrics. Anthropometric measurements of each
child were obtained at enrollment and at the time of neuro-
developmental testing at 78 and 104 weeks. The length of
each child was measured to the nearest 0.1 cm (Infantometer
Baby Board, Seca 416). Each child was weighed in light
clothing on an electronic scale (Digital Baby and Toddler
Scales, Seca 354), and theweightwas recorded to the nearest
0.01 kg. Length and weight measurements were taken twice,
and the average of the two measurements was recorded.
Anthropometric measurements were converted to length-for-
age Z-score (LAZ) and weight-for-age Z-score (WAZ) using
WHO Anthro software, version 3.0.1 (Geneva, Switzerland).
Biomarkermeasurement.Sera from infants at 18weeks of
age were tested for IL-1β, IL-6, TNF-α, IL-4, and IL-10 using
Human Bio-Plex Pro Assays (N = 422). sCD14 was also
measured in infant sera at 18 weeks of age using enzyme-
linked immunosorbent assay (ELISA) (R and D Systems,
Minneapolis, MN). CRP wasmeasured in sera at 6, 18, 40, 53,
and 104 weeks using an ELISA (Immundiagnostik AG).
Neurodevelopment measurement. Trained child psychol-
ogists, blinded to the children’s histories and clinical param-
eters, assessed cognitive, language, motor, and social
emotional development in a clinic setting using a culturally
adapted version of theBayley-III at 78 (N=205) and104weeks
(N = 422). The Bayley-III raw scores for cognitive, language,
motor, and social emotional development were converted to
norm-referenced standardized scores (mean = 100, standard
deviation [SD] = 15) for composite scales. Ten percent of all
tests (N= 35) were observed by the supervisor (FT) throughout
the studyperiod for ongoing reliability. TheBayleyScales have
been used by the same research group in several previous
studies in rural and urban settings in Bangladesh. Field testing
of the instrument showed positive correlations of the Bayley
scoreswith child nutritional status and parental education (P<
0.05). Assessment of short-term test–retest reliability (within
7 days) indicated high correlation (r > 0.80). Interobserver re-
liability (intraclass correlation) between tester and trainer was
high (r = 0.99).6
Maternal depression.Maternal depression wasmeasured
using the Edinburgh Postnatal Depression Scale (EPDS). The
EPDS has been validated for use in the postnatal period22 and
has also been validated in Bangladesh.23 The EPDS is a 10-
itemscale that results in a score ranging from0 to30.While the
scale alone cannot conﬁrm a diagnosis of depression, a score
10 and above is indicative of the presence of a depressive
disorder.24
Statistical analysis. Infants’characteristics and risk factors
were summarized as counts and percentages for categorical
variables and as mean ±SD for continuous variables. For the
neurodevelopmental outcomes, we assessed associations of
inﬂammatory markers with the outcomes using linear re-
gression analysis. We ﬁrst evaluated the effect of baseline
variables and inﬂammatory markers at 78 and 104 weeks on
Bayley-III scores using univariate analysis. Based on the re-
sults of the univariate analysis, we further performed multi-
variable analysis to evaluate the associations of biological
markers of inﬂammation with neurodevelopmental outcomes
after adjusting for baseline characteristics or potential con-
founders. As many biomarkers are correlated, such as LAZ
and WAZ, we chose only one representative variable from
each category we wished to control for. Final multivariable
analyses were adjusted for potential confounders of sex,
family income, maternal education, and child’s anthropo-
metric status at the time of neurodevelopmental testing.
Because of their skewed distributions, cytokine concen-
trations values were dichotomized into the highest quartile
and lower three quartiles. In our ﬁnal models, the cytokine
measures were analyzed as binary variables (top quartile
versus lower three quartiles) as we were most interested in
the contribution of elevated levels of cytokines on neuro-
development. To examine the effect of elevated CRP levels
across several time points, an elevated CRP was deﬁned as
a value greater than the median CRP value at any particular
time point. Statistical signiﬁcance was deﬁned as a P value
of < 0.05 (two-tailed). Data were analyzed using IBM SPSS 20
(SPSS Inc., Chicago, IL).
RESULTS
Description of the study population. The Bayley Scales
weremeasured in 205children at 78weeks and422children at
104 weeks. The Bayley test was administrated to the cohort
during an extension phase, and thus 217 children missed the
neurodevelopmental measurement at 78 weeks because they
were already older than 78 weeks. More than half of children
(51.7%) were boys. The children, on average, were malnour-
ished, living in impoverished conditions, and experienced re-
current infection during childhood (Table 1). The children
tested at 78 and 104 weeks with the Bayley-III were compa-
rable in their baseline characteristics. The mean household
incomewas < 13,500 taka (BDT) per month (< $174USD), and
about 30% of mothers had no formal education. Average LAZ
and WAZ scores declined over the following 104 weeks. At
birth, 10%ofchildrenwere stunted (LAZ<_2); by104weeksof
age, nearly 40% of children were stunted (Table 1). The mean
cognitive, language, motor, and social emotional composite
scores at 78 weeks of age were 95.1 ± 6.6 (mean ± SD), 97.0 ±
8.3, 97.2 ± 6.2, and 88.8 ± 6.2, respectively. The mean cog-
nitive, language, motor, and social emotional composite
scores at 104 weeks of age were 90.5 ± 5.7, 98.5 ± 8.4, 94.9 ±
7.4, and 94.3 ± 5.6, respectively.
Malnutrition, socioeconomic status, maternal factors,
and cytokines. Univariate linear regression analyses showed
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that malnutrition, low socioeconomic status, low maternal ed-
ucation, and maternal depression were signiﬁcantly and ad-
versely associated with Bayley-III scores at both time points
(data not shown). Of note, linear regression showed that ele-
vated levels of IL-1β, IL-6, IL-10, and TNF-α were signiﬁcantly
associated with lower language, and elevated IL-1β also to
lower cognitive, language, and social emotional scores at 78
but not 104 weeks (data not shown).
Soluble CD14 and neurodevelopmental outcomes.
sCD14was associated with lower Bayley-III outcomes across
domains (cognition and motor at 78 weeks [data not shown];
all domains at week 104) (Figure 1). The association of sCD14
with Bayley outcomes remained signiﬁcant in multivariable
analysis after controlling for sex, maternal education, monthly
family income, and stunting at the time of testing (Table 2).
CRP and neurodevelopmental outcomes. The cumula-
tive number of CRP elevation at 6, 18, 40, 53, and 104 weeks
of age was used as a measure of sustained inﬂammation.
We found that elevated CRPs (deﬁned as a value above the
median for the age of the child) at 40 and 53 weeks, but
not 104 weeks of age, were associated with lower Bayley-III
outcomes. In addition, the cumulative number of CRP eleva-
tions that a child experienced was also associated with lower
Bayley-III results. Figure 2 shows the signiﬁcant differences in
developmental scores between children with normal CRP and
those with elevated CRP at 104 weeks. The association of
elevated CRP at 40 weeks with developmental scores at
104 weeks remained signiﬁcant in multivariable analysis after
controlling for the same confounders as described earlier
(Table 3).
DISCUSSION
The most signiﬁcant contribution of this study is the vali-
dation in an independent cohort of our earlier ﬁnding that early
life inﬂammation is associatedwith lower neurodevelopmental
outcomes in a cohort of children growing up in profound ad-
versity.6 We found that higher levels of sCD14 in sera was
signiﬁcantly associated with lower neurodevelopmental out-
comes in all four domains tested. We also found in this study
that IL-1β was signiﬁcantly associated with lower cogni-
tive, language, and social emotional development. Similarly,
TABLE 1
Descriptive characteristics of the study population of the total cohort at 78 and 104 weeks
Characteristic 78 weeks (N = 205) 104 weeks (N = 422)
Male sex (%) 106 (51.7) 218 (51.7)
No maternal education (%) 64 (31.2) 124 (29.4)
Monthly family income (BDT) 13264 ± 10183 13408 ± 10101
Maternal BMI < 18.5 (%) 35 (17.1) 74 (17.5)
Edinburgh Postnatal Depression* 108 (55.1) 200 (48.2)
Exclusive breast feeding (days) 98.2 ± 42.7 97.4 ± 41.7
LAZ at birth _0.91 ± 0.81 _0.94 ± 0.84
Diarrheal illness (total days)† 4.9 ± 6.9 5.6 ± 7.6
ARI = acute respiratory infection; BDT = Bangladeshi taka (currency); BMI = body mass index; LAZ = length-for-age Z-score; SD = standard deviation. Data are expressed as count (%) for
categorical measures and mean ± SD for continuous measures.
* Scale > 10 (%).
† During ﬁrst year of life.
FIGURE 1. Increased soluble CD14 levels in sera at 18 weeks of age are associated with decreased developmental scores at 104 weeks of age.
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elevated levels of the acute phase reactant CRP were asso-
ciated with lower developmental outcomes in all domains.
The discovery that sCD14 can serve as a marker of neuro-
development has several important implications. First, our
ﬁndings of an association of both sCD14 and downstream
markers (IL-1β and IL-6)20 suggests a common pathway of
associated inﬂammation. Together, these ﬁndings are all
consistent with the notion that systemic inﬂammation has a
deleterious effect on the developing brain.
Second, the association of sCD14 with neurodevelop-
mental outcomes may shed light on biological mechanisms
that link inﬂammation with the brain. Although it has been long
appreciated that adversity has a detrimental impact on the
developing brain, mechanisms that underlie this association
still remain unknown.25 The association of sCD14 with de-
velopmental outcomes implicates a role of the LPS–CD14
pathway in the pathogenesis of neuronal damage. sCD14 has
been used in studies in human immunodeﬁciency virus pa-
tients as a marker of microbial translocation, indicating gut
barrier dysfunction.16,26 The association of sCD14 with de-
velopmental outcomes suggests that EE from repeated en-
teric infections may result in the systemic inﬂammatory
response we see as measured by the proinﬂammatory cyto-
kine IL-1β and the acute-phase reactant CRP. In fact, the
children in this study had on average two different enter-
opathogens detected in their stool at both 6 and 10 weeks of
age and EE (deﬁned by abnormal levels of fecal calprotectin,
myeloperoxidase, or alpha-1-antitrypsin) in 80%.11 These
ﬁndings therefore may point to a novel mechanism by which
adversity can impact the brains of young children via EE and
systemic inﬂammation.
Third, the association of sCD14 with neurodevelopment
may have potential therapeutic implications. If activation of
CD14 is the beginning of the pathway, targeted interventions
at CD14 could potentially be used to limit excessive inﬂam-
mation via this pathway and improve outcomes in children. In
one study, peripheral blood leukocytes from preterm infants
were treated with anti-CD14-blocking antibodies and sub-
sequently stimulated with LPS. CD14 blockade resulted in a
signiﬁcant decrease in the proinﬂammatory cytokine IL-8.27
Our study has several key limitations that should be noted.
The Bayley-III Scale has not been normalized for the Bangla-
desh population, so it is not possible to characterize the re-
sults as normal or abnormal. However, the Bayley Scale
allowed for internally consistent comparison of children within
the cohort. A second limitation was that sCD14, IL-1β, and
IL-6 were measured at only 18 weeks, leaving open the pos-
sibility that other adversities between 18 weeks and the
measurement of Bayley Scales at 78 and 104 weeks of age.
We, however, did measure levels of CRP over multiple time
points that were associated with neurodevelopmental scores
at several time points. Finally, as inﬂammatory cytokines may
be activated through other pathways than LPS–sCD14, our
study provides only one possible hypothesis for the mecha-
nism by which systemic inﬂammation is induced in children
who grow up in adversity.
In summary, thepresent studyhighlights inﬂammation as an
independent risk factor for impaired infant development. To
the best of our knowledge, this is the ﬁrst study to correlate
levels of sCD14 in sera of children with neurodevelopmental
outcomes later in life. The causal relationship of the activation
ofCD14and subsequent releaseof downstream inﬂammatory
markers needs to be further investigated. An increased un-
derstanding of the interactions between gut inﬂammation,
cytokine levels, and neurocognitive function could allow us to
TABLE 2
Effect of sCD14 on developmental outcomes at 104 weeks adjusting for sex, monthly family income, maternal education, and LAZ at 104 weeks
Predictors
Cognitive Composite Score Language Composite Score Motor Composite Score
Social Emotional Composite
Score
Estimate (SE)* P value Estimate (SE)* P value Estimate (SE)* P value Estimate (SE)* P value
Male sex 0.02 (0.55) 0.705 0.14 (0.81) 0.005 _0.02 (0.72) 0.730 0.13 (0.52) 0.006
Monthly family income 0.15 (0.00) 0.003 0.11 (0.00) 0.031 0.03 (0.00) 0.557 0.15 (0.00) 0.003
Maternal education (years) _0.08 (0.61) 0.092 _0.11 (0.90) 0.024 _0.07 (0.81) 0.175 _0.83 (0.58) 0.087
LAZ at 104 weeks (every unit) 0.19 (0.29) < 0.001 0.16 (0.43) 0.002 0.15 (0.38) 0.004 0.21 (0.27) < 0.001
sCD14 at 18 weeks _0.13 (0.37) 0.008 _0.11 (0.001) 0.022 _0.13 (0.00) 0.011 _0.19 (0.00) < 0.001
LAZ = length-for-age Z-score; sCD14 = soluble CD14; SE = standard error. Bolded values represent a P value < 0.05.
* Estimated effect of male sex, monthly family income, maternal education, LAZ at 104 weeks, and sCD14 at 18 weeks on developmental outcomes expressed as the magnitude change in
developmental scores for every taka in family income, year of maternal education, and increment in LAZ at 104 weeks. Data in parentheses are SEs for the corresponding covariate effect.
FIGURE 2. Elevated levels of C-reactive protein at 40 weeks of life
are associated with lower developmental scores at 104 weeks of life.
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identify at-risk children early for targeted interventions, to al-
low every child to meet their full developmental potential.
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LAZ at 104 weeks (every unit) 0.18 (0.28) < 0.001 0.15 (0.42) 0.003 0.17 (0.37) 0.001 0.21 (0.27) < 0.001
Elevated CRP at 40 weeks _0.15 (0.54) 0.002 _0.10 (0.81) 0.035 _0.11 (0.73) 0.033 _0.12 (0.52) 0.012
CRP = C-reactive protein; LAZ = length-for-age Z-score; SE = standard error. Bolded values represent a P value < 0.05.
* Estimated effect of male sex, monthly family income, maternal education, LAZ at 104 weeks, and CRP at 40 weeks on developmental outcomes expressed as the magnitude change in
developmental scores for every taka in family income, year of maternal education, and increment in LAZ at 104 weeks. Data in parentheses are SEs for the corresponding covariate effect.
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